The influence of adiposity and acute exercise on circulating hepatokines in normal-weight and overweight/obese men.

Hepatokines are liver-secreted proteins with potential to influence glucose regulation and other metabolic parameters. This study investigated differences in adiposity status on 5 novel hepatokines and characterised their response to acute moderate-intensity exercise in groups of normal-weight and overweight/obese men. Twenty-two men were recruited into normal-weight and overweight/obese groups (body mass index: 18.5 to 24.9 and 25.0 to 34.9 kg·m-2). Each completed 2 experimental trials, exercise and control. During exercise trials, participants performed 60 min of moderate-intensity treadmill exercise (∼60% peak oxygen uptake) and then rested for 6 h. Participants rested throughout control trials. Circulating fibroblast growth factor-21 (FGF21), follistatin, leukocyte cell-derived chemotaxin 2 (LECT2), fetuin-A, and selenoprotein-P (SeP) were measured throughout. Fasted (resting) FGF21 and LECT2 were higher in overweight/obese individuals (129% and 55%; P ≤ 0.01) and correlated with indices of adiposity and insulin resistance; whereas circulating follistatin was lower in overweight/obese individuals throughout trial days (17%, P < 0.05). In both groups, circulating concentrations of FGF21 and follistatin were transiently elevated after exercise for up to 6 h (P ≤ 0.02). Circulating fetuin-A and SeP were no different between groups (P ≥ 0.19) and, along with LECT2, were unaffected by exercise (P ≥ 0.06). These findings show that increased adiposity is associated with a modified hepatokine profile, which may represent a novel mechanism linking excess adiposity to metabolic health. Furthermore, acute perturbations in circulating FGF21 and follistatin after exercise may contribute to the health benefits of an active lifestyle.

[1]  F. Izaddoust Homeostatic Model Assessment of Insulin Resistance , 2020, Definitions.

[2]  G. Borg Perceived exertion as an indicator of somatic stress. , 2019, Scandinavian journal of rehabilitation medicine.

[3]  Maximilian Kleinert,et al.  Exercise-stimulated glucose uptake — regulation and implications for glycaemic control , 2017, Nature Reviews Endocrinology.

[4]  Guowang Xu,et al.  Exercise-Induced Secretion of FGF21 and Follistatin Are Blocked by Pancreatic Clamp and Impaired in Type 2 Diabetes. , 2016, The Journal of clinical endocrinology and metabolism.

[5]  S. Kaneko,et al.  Development of a Sol Particle Homogeneous Immunoassay for Measuring Full‐Length Selenoprotein P in Human Serum , 2016, Journal of clinical laboratory analysis.

[6]  N. Secher,et al.  Circulating Follistatin Is Liver-Derived and Regulated by the Glucagon-to-Insulin Ratio. , 2016, The Journal of clinical endocrinology and metabolism.

[7]  Robert J A Goode,et al.  Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism. , 2015, Cell metabolism.

[8]  A. Slusher,et al.  Attenuated fibroblast growth factor 21 response to acute aerobic exercise in obese individuals. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[9]  J. Trepanowski,et al.  Fetuin-A: a novel link between obesity and related complications , 2014, International Journal of Obesity.

[10]  Hazel Huang,et al.  Exercise-induced lowering of fetuin-A may increase hepatic insulin sensitivity. , 2014, Medicine and science in sports and exercise.

[11]  Y. Fukumoto,et al.  High plasma fetuin-A levels are associated with metabolic syndrome among males but not females in a Japanese general population. , 2014, Diabetes research and clinical practice.

[12]  S. Kaneko,et al.  LECT2 Functions as a Hepatokine That Links Obesity to Skeletal Muscle Insulin Resistance , 2014, Diabetes.

[13]  Y. Kaburagi,et al.  Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver. , 2013, Bioscience trends.

[14]  C. Flask,et al.  Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease. , 2013, Journal of applied physiology.

[15]  A. S. Andreasen,et al.  Plasma follistatin is elevated in patients with type 2 diabetes: relationship to hyperglycemia, hyperinsulinemia, and systemic low‐grade inflammation , 2013, Diabetes/metabolism research and reviews.

[16]  H. J. Yoo,et al.  Salsalate and Adiponectin Improve Palmitate-Induced Insulin Resistance via Inhibition of Selenoprotein P through the AMPK-FOXO1α Pathway , 2013, PloS one.

[17]  G. Shulman,et al.  Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice. , 2013, Endocrinology.

[18]  Y. Min,et al.  Acute Exercise Induces FGF21 Expression in Mice and in Healthy Humans , 2013, PloS one.

[19]  H. J. Yoo,et al.  Increased Selenoprotein P Levels in Subjects with Visceral Obesity and Nonalcoholic Fatty Liver Disease , 2013, Diabetes & metabolism journal.

[20]  S. Kliewer,et al.  Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. , 2012, Genes & development.

[21]  K. Birkeland,et al.  Activin A and cardiovascular disease in type 2 diabetes mellitus , 2012, Diabetes & vascular disease research.

[22]  A. Xu,et al.  Research Design and Methods , 2005, Hormone Research in Paediatrics.

[23]  H. J. Yoo,et al.  Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. , 2011, The Journal of clinical endocrinology and metabolism.

[24]  Yu Xu,et al.  Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese. , 2011, Atherosclerosis.

[25]  M. Honda,et al.  A liver-derived secretory protein, selenoprotein P, causes insulin resistance. , 2010, Cell metabolism.

[26]  K. Xiang,et al.  Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. , 2010, Journal of hepatology.

[27]  G. Boden Obesity and free fatty acids. , 2008, Endocrinology and metabolism clinics of North America.

[28]  K. Reynolds,et al.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). , 2008, Archives of internal medicine.

[29]  Feng Liu,et al.  Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans , 2008, Diabetes.

[30]  Amalia Gastaldelli,et al.  Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. , 2007, Gastroenterology.

[31]  J. Flier,et al.  Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. , 2007, Cell metabolism.

[32]  D. Wasserman,et al.  Energy state of the liver during short-term and exhaustive exercise in C57BL/6J mice. , 2006, American journal of physiology. Endocrinology and metabolism.

[33]  Kazuhiko Takahashi,et al.  Production and Application of Monoclonal Antibodies to Human Selenoprotein P , 2001 .

[34]  D. Gospodarowicz,et al.  Fibroblast growth factor , 1986, Molecular and Cellular Endocrinology.

[35]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[36]  D. Costill,et al.  Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. , 1974, Journal of applied physiology.

[37]  Xiaomin Sun,et al.  Endurance Exercise Reduces Hepatic Fat Content and Serum Fibroblast Growth Factor 21 Levels in Elderly Men. , 2016, The Journal of clinical endocrinology and metabolism.

[38]  M. Bemben,et al.  Acute bone marker responses to whole-body vibration and resistance exercise in young women. , 2013, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.